TARO PHARMACEUTICAL INDUSTRIES LTD — key financial figures for fiscal year 2022 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2022)

$573.0M

Net Income/Loss (FY2022)

$25.4M

Total Assets (FY2022)

$2.1B

Total Equity (FY2022)

$1.7B

Cash Flows from Operating Activities (FY2022)

$31.8M

Source: TARO PHARMACEUTICAL INDUSTRIES LTD 20-F filing (FY2022). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.